文献速递眼底病与葡萄膜炎眼外伤

白内障术后多重耐药急性细菌性眼内炎的临床与微生物学特征:眼内炎管理研究报告第8号

Clinical and microbiological characteristics of multidrug-resistant acute bacterial endophthalmitis after cataract surgery. Endophthalmitis Management Study Report # 8.
PubMed 文献 · Retina · 2026-01-01

印度前瞻性多中心研究连续分析32例白内障术后多重耐药急性细菌性眼内炎,多重耐药发生率为7.8%(32/410),以革兰阴性杆菌为主(87.5%)。主要治疗为玻璃体切除联合玻璃体腔注射抗生素,所有患者均需二次干预。作者认为粘菌素可作为治疗印度革兰阴性杆菌所致多重耐药白内障术后眼内炎的替代选择。

要点

  • 多重耐药发生率为7.8%(32/410),其中革兰阴性杆菌占87.5%(28/32),革兰阳性球菌占12.5%(4/32)。
  • 就诊视力为光感至手动者占93.9%(30/32),平均炎症评分为17.34±3.96。
  • 治疗后9.4%患眼发生眼球萎缩,46.9%视力未改善,9.4%患眼视力≥20/40。

核心结论

  • 作者认为粘菌素可作为治疗印度革兰阴性杆菌所致多重耐药白内障术后眼内炎的替代选择。

研究设计与样本

  • 印度前瞻性多中心研究,连续纳入32例白内障术后多重耐药急性细菌性眼内炎病例,分析治疗前及治疗后3个月的临床特征、就诊视力与炎症评分。

主要发现

  • 多重耐药发生率为7.8%(32/410),包括革兰阴性杆菌28株(87.5%)和革兰阳性球菌4株(12.5%)。
  • 就诊视力为光感至手动者占93.9%(30/32),平均炎症评分为17.34±3.96。
  • 主要治疗为玻璃体切除联合玻璃体腔注射抗生素,所有患者均需二次干预即玻璃体灌洗联合玻璃体腔注射抗生素(平均2.43次)。
  • 革兰阴性杆菌对氟喹诺酮类、氨基糖苷类和头孢菌素类的耐药率各为39.3%,对多粘菌素类的耐药率为17.6%。
  • 多数对阿米卡星和头孢他啶耐药(81.8%)的革兰阴性杆菌对粘菌素敏感。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Report the clinico-microbiological characteristics of multidrug-resistant acute postcataract bacterial endophthalmitis. METHODS: Consecutive 32 cases from a prospective multicenter study in India were analyzed for the clinical features, presenting visual acuity, and inflammation score before and 3 months after treatment. Absolute risk reduction and number needed to treat to avoid globe loss were calculated. RESULTS: The multidrug-resistant incidence was 7.8% (32/410). It included 28 gram-negative bacilli (GNB, 87.5%) and 4 gram-positive cocci (GPC, 12.5%). The presenting visual acuity was light perception to hand motions in 93.9% (30/32) of patients. The mean inflammation score was 17.34 ± 3.96. The primary treatment was vitrectomy and intravitreal antibiotics; all patients required a second intervention-vitreous lavage and intravitreal antibiotics (mean 2.43). GNBs were resistant to fluoroquinolones, aminoglycosides, and cephalosporins (39.3% each) and polymyxins (17.6%). Most amikacin- and ceftazidime-resistant (81.8%) GNBs were susceptible to colistin. After treatment, 9.4% of eyes developed phthisis, 46.9% did not improve vision, and 9.4% of eyes had ≥20/40. The absolute risk reduction was higher and the number needed to treat was lower to avoid one globe loss with colistin than with other antibiotics. CONCLUSION: Colistin could be an alternative to treating multidrug-resistant postcataract endophthalmitis caused by gram-negative bacilli in India.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Das T, Belenje A, Joseph J, et al. Clinical and microbiological characteristics of multidrug-resistant acute bacterial endophthalmitis after cataract surgery. Endophthalmitis Management Study Report # 8. Retina. 2026. PMID: 41111240. doi:10.1097/IAE.0000000000004696

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。